BRTX EBITDA | BIORESTORATIVE THERAPIES, INC.

BIORESTORATIVE THERAPIES, INC. (BRTX) EBITDA

2026-03-31: Basis Reported; EBITDA (m); Operating income -$3.39M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$3.71M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$3.31M; Depreciation and amortization (m).
2025-03-31: Basis Reported; EBITDA (m); Operating income -$4.81M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2010-12-31 to 2023-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-03-31	Reported	(m)	-$3.39M	(m)	$23.17K	(m)	(m)	-$3.81M	$7.38K	$1.93M	(m)	(m)
2025-09-30	Reported	(m)	-$3.71M	(m)	$11.80K	(m)	$0.00*	-$2.90M*	$10.57K	$2.59M	(m)	(m)
2025-06-30	Reported	(m)	-$3.31M	(m)	$303.30K	(m)	$0.00*	-$2.69M*	$8.73K	$2.23M	(m)	(m)
2025-03-31	Reported	(m)	-$4.81M	(m)	$25.00K	(m)	$36.40K	-$2.78M	$2.91K	$2.65M	(m)	(m)
2024-09-30	Reported	(m)	-$2.29M	(m)	$233.60K	(m)	$58.46K*	-$1.70M*	$18.24K	$1.45M	(m)	(m)
2024-06-30	Reported	(m)	-$2.47M	(m)	$89.10K	(m)	(m)	-$1.87M*	$6.49K	$1.45M	(m)	(m)
2024-03-31	Reported	(m)	-$4.11M	(m)	$35.00K	(m)	(m)	-$2.32M	(m)	$1.06M	(m)	(m)
2023-09-30	Reported	(m)	-$3.10M	(m)	$30.70K	(m)	$11.95K*	-$1.18M*	(m)	$809.82K	(m)	(m)
2023-06-30	Reported	-$3.08M*	-$3.12M	$41.53K*	$64.50K	-4767.48%*	$29.05K*	(m)	(m)	$902.89K	(m)	(m)
2023-03-31	Reported	-$5.74M	(m)	(m)	(m)	-18337.85%	$60.02K	(m)	(m)	$1.23M	(m)	(m)
2022-12-31	Reported	-$4.65M	(m)	(m)	(m)	-125678.65%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$4.58M*	-$4.61M	$31.23K*	$29.00K	-15787.84%*	-$24.61K*	-$1.45M*	(m)	$989.17K	(m)	(m)
2022-06-30	Reported	-$4.60M*	-$4.63M	$31.52K*	$71.10K	-6465.70%*	$137.67K*	-$1.25M*	(m)	$1.08M	(m)	(m)
2022-03-31	Reported	-$5.03M	(m)	(m)	(m)	-31423.64%	$109.57K	-$1.59M	(m)	$775.34K	(m)	(m)
2021-12-31	Reported	-$3.99M	(m)	(m)	(m)	-79755.42%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$3.67M*	-$3.69M	$21.58K*	$8.00K	-45838.88%*	(m)	-$629.36K*	(m)	$237.41K	(m)	(m)
2021-06-30	Reported	-$3.53M*	-$3.56M	$21.83K*	$15.00K	-23556.19%*	(m)	-$741.83K*	(m)	$160.90K	(m)	(m)
2021-03-31	Reported	-$15.03M	(m)	(m)	(m)	-83502.53%	(m)	-$813.70K	(m)	$165.25K	(m)	(m)
2020-12-31	Reported	-$828,998.00	(m)	(m)	(m)	-4876.46%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$584.80K*	-$610.26K	$25.47K*	$15.00K	-3898.65%*	(m)	-$523.06K*	(m)	$251.04K	(m)	(m)
2020-06-30	Reported	-$434.90K*	-$461.59K	$26.68K*	$19.00K	-2288.96%*	(m)	-$420.44K*	(m)	$261.55K	(m)	(m)
2020-03-31	Reported	-$775,225.00	(m)	(m)	(m)	-2981.63%	(m)	-$448.65K	(m)	$186.33K	(m)	(m)
2019-12-31	Reported	-$2.1M	(m)	(m)	(m)	-6562.27%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$1.76M*	-$1.82M	$55.77K*	$38.00K	-4640.07%*	$6.26K*	-$1.71M*	(m)	$409.81K	(m)	(m)
2019-06-30	Reported	-$2.08M*	-$2.13M	$52.98K*	$31.00K	-6696.19%*	(m)	-$1.42M*	(m)	$441.72K	(m)	(m)
2019-03-31	Reported	-$2.28M	(m)	(m)	(m)	-7847.15%	(m)	-$1.98M	(m)	$455.01K	(m)	(m)
2018-12-31	Reported	-$2.12M	(m)	(m)	(m)	-7312.44%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$1.13M*	-$1.19M	$61.45K*	$26.00K	-4335.48%*	$0.00*	-$1.35M*	(m)	$357.44K	(m)	(m)
2018-06-30	Reported	-$1.99M*	-$2.05M	$61.04K*	$37.00K	-5376.47%*	(m)	-$1.04M*	(m)	$372.81K	(m)	(m)
2018-03-31	Reported	-$2.17M	(m)	(m)	(m)	-11421.86%	(m)	-$1.16M	(m)	$407.13K	(m)	(m)
2017-12-31	Reported	-$1.51M	(m)	(m)	(m)	-3968.93%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$1.68M*	-$1.74M	$65.70K*	(m)	(m)	(m)	-$509.16K*	(m)	$490.65K	(m)	(m)
2017-06-30	Reported	-$2.50M*	-$2.57M	$65.19K*	(m)	(m)	(m)	(m)	(m)	$610.73K	(m)	(m)
2017-03-31	Reported	-$2.43M	(m)	(m)	(m)	-34643.97%	(m)	(m)	(m)	$805.85K	(m)	(m)
2016-12-31	Reported	-$1.79M	(m)	(m)	(m)	-29528.86%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$1.65M*	-$1.72M	$65.54K*	(m)	(m)	$30.74K*	(m)	(m)	$656.17K	(m)	(m)
2016-06-30	Reported	-$2.08M*	-$2.14M	$64.79K*	(m)	(m)	$61.34K*	(m)	(m)	$608.69K	(m)	(m)
2016-03-31	Reported	-$2M	(m)	(m)	(m)	-21969.78%	$89.86K	(m)	(m)	$866.04K	(m)	(m)
2015-12-31	Reported	-$2.73M	(m)	(m)	(m)	-1370.25%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$1.43M*	-$1.49M	$61.19K*	(m)	(m)	$208.55K*	(m)	(m)	$615.65K	(m)	(m)
2015-06-30	Reported	-$1.21M*	-$1.26M	$49.84K*	(m)	(m)	$59.74K*	(m)	(m)	$452.49K	(m)	(m)
2015-03-31	Reported	-$1.59M	(m)	(m)	(m)	-857.94%	$92.17K	(m)	(m)	$406.86K	(m)	(m)
2014-12-31	Reported	-$1.29M	(m)	(m)	(m)	-1622.32%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$872.26K*	-$896.01K	$23.75K*	(m)	(m)	$1.53K*	(m)	(m)	$290.71K	(m)	(m)
2014-06-30	Reported	-$1.26M*	-$1.28M	$24.62K*	(m)	(m)	$0.00*	(m)	(m)	$293.33K	(m)	(m)
2014-03-31	Reported	-$1.4M	(m)	(m)	(m)	-374106.93%	$0.00	-$806.73K	(m)	$493.74K	(m)	(m)
2013-12-31	Reported	-$1.18M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$1.10M*	-$1.13M	$25.96K*	(m)	(m)	$0.00*	-$434.39K*	(m)	$414.92K	(m)	(m)
2013-06-30	Reported	-$1.09M*	-$1.11M	$26.37K*	(m)	(m)	$0.00*	-$702.49K*	(m)	$372.92K	(m)	(m)
2013-03-31	Reported	-$1.27M	(m)	(m)	(m)	-112641.24%	$0.00	-$771.77K	(m)	$400.44K	(m)	(m)
2012-12-31	Reported	-$1.68M	(m)	(m)	(m)	-460669.51%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$1.18M*	-$1.21M	$27.01K*	(m)	(m)	$0.00*	-$450.88K*	(m)	$275.31K	(m)	(m)
2012-06-30	Reported	-$1.33M*	-$1.34M	$10.35K*	(m)	(m)	$2.53K*	-$1.26M*	(m)	$119.35K	(m)	(m)
2012-03-31	Reported	-$1.3M	(m)	(m)	(m)	(m)	$0.00	-$393.89K	(m)	$53.70K	(m)	(m)
2011-12-31	Reported	-$630,469.00	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$827.69K*	-$853.00K	$25.31K*	(m)	(m)	$0.00*	-$274.57K*	(m)	$0.00	(m)	(m)
2011-06-30	Reported	-$1.01M*	-$1.04M	$27.65K*	(m)	(m)	$10.88K*	-$570.84K*	(m)	(m)	(m)	(m)
2011-03-31	Reported	-$992,852.00	(m)	(m)	(m)	(m)	$6.89K	-$849.91K	(m)	(m)	(m)	(m)
2010-12-31	Reported	-$1.15M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$362.09K*	-$370.19K	$8.11K*	(m)	(m)	$70.30K*	$28.43K*	(m)	$0.00*	(m)	(m)
2010-06-30	Reported	(m)	-$178.73K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$15.65M	(m)	$359.70K	(m)	$116.07K	-$10.79M	$23.84K	$10.09M	(m)	(m)
2024-12-31	Reported	(m)	-$11.56M	(m)	$401.00K	(m)	$106.19K	-$8.23M	$28.07K	$6.71M	(m)	(m)
2023-12-31	Reported	(m)	-$15.22M	(m)	$145.80K	(m)	$171.04K	-$6.43M	(m)	$4.03M	(m)	(m)
2022-12-31	Reported	-$18.85M	(m)	(m)	(m)	-15737.46%	$265.22K	-$5.91M	(m)	$3.51M	(m)	(m)
2021-12-31	Reported	-$26.22M	(m)	(m)	(m)	-56997.32%	$30.66K	-$3.33M	(m)	$729.06K	(m)	(m)
2020-12-31	Reported	-$2.63M	(m)	(m)	(m)	-3416.48%	(m)	-$1.96M	(m)	$876.83K	(m)	(m)
2019-12-31	Reported	-$8.21M	(m)	(m)	(m)	-6318.96%	$35.63K	-$6.92M	(m)	$1.72M	(m)	(m)
2018-12-31	Reported	-$7.41M	(m)	(m)	(m)	-6673.23%	$12.87K	-$5.10M	(m)	$1.51M	(m)	(m)
2017-12-31	Reported	-$8.12M	(m)	(m)	(m)	-10018.55%	$3.62K	-$3.85M	(m)	$2.15M	(m)	(m)
2016-12-31	Reported	-$7.53M	(m)	(m)	(m)	-20703.20%	$188.76K	(m)	(m)	$2.88M	(m)	(m)
2015-12-31	Reported	-$6.96M	(m)	(m)	(m)	-1106.12%	$408.07K	(m)	(m)	$2.11M	(m)	$0.00
2014-12-31	Reported	-$4.83M	(m)	(m)	(m)	-1160.06%	$168.38K	(m)	(m)	$1.43M	(m)	$0.00
2013-12-31	Reported	-$4.65M	(m)	(m)	(m)	-276634.46%	$11.16K	-$2.67M	(m)	$1.59M	(m)	$0.00
2012-12-31	Reported	-$5.48M	(m)	(m)	(m)	-35166.13%	$2.53K	-$3.18M	(m)	$756.78K	(m)	(m)
2011-12-31	Reported	-$3.46M	(m)	(m)	(m)	(m)	$17.77K	-$2.81M	(m)	$12.00K	(m)	(m)
2010-12-31	Reported	-$2.02M	(m)	(m)	(m)	(m)	$45.38K	-$729.22K	(m)	$11.62K	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Park Dental Partners, Inc. (PARK)	United States	$0.094B
CRYO CELL INTERNATIONAL INC (CCEL)	United States	$0.033B	-11.02
MANGOCEUTICALS, INC. (MGRX)	United States	$0.010B	-0.43
VIEMED HEALTHCARE, INC. (VMD)	United States	$0.336B	29.92
agilon health, inc. (AGL)	United States	$1.272B	-7.76
Progyny, Inc. (PGNY)	United States	$1.994B	28.37
Sotera Health Co (SHC)	United States	$5.271B	30.96
DAVITA INC. (DVA)	United States	$11.147B	16.80